Consensus molecular classification of triple-negative breast cancers
RNA-seq (gene expression) · human · 48 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 48 samples: 48 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtypeBreast cancer (Tokyo, Japan) · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE225002_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA933542. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 48 sample titles: 48 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7036855 TNBC_01_FF
- GSM7036856 TNBC_02_FF
- GSM7036857 TNBC_03_FF
- GSM7036858 TNBC_04_FF
- GSM7036859 TNBC_05_FF
- GSM7036860 TNBC_06_FF
- GSM7036861 TNBC_07_FF
- GSM7036862 TNBC_08_FF
- GSM7036863 TNBC_09_FF
- GSM7036864 TNBC_10_FF
- GSM7036865 TNBC_11_FF
- GSM7036866 TNBC_12_FF
- GSM7036867 TNBC_13_FF
- GSM7036868 TNBC_14_FF
- GSM7036869 TNBC_15_FF
- GSM7036870 TNBC_16_FF
- GSM7036871 TNBC_17_FF
- GSM7036872 TNBC_18_FF
- GSM7036873 TNBC_19_FF
- GSM7036874 TNBC_20_FF
- GSM7036875 TNBC_21_FF
- GSM7036876 TNBC_22_FF
- GSM7036877 TNBC_23_FF
- GSM7036878 TNBC_24_FF
- GSM7036879 TNBC_25_FF
- GSM7036880 TNBC_26_FF
- GSM7036881 TNBC_27_FF
- GSM7036882 TNBC_28_FF
- GSM7036883 TNBC_29_FF
- GSM7036884 TNBC_30_FF
- GSM7036885 TNBC_31_FF
- GSM7036886 TNBC_32_FF
- GSM7036887 TNBC_33_FF
- GSM7036888 TNBC_34_FF
- GSM7036889 TNBC_35_FF
- GSM7036890 TNBC_36_FF
- GSM7036891 TNBC_37_FF
- GSM7036892 TNBC_38_FF
- GSM7036893 TNBC_39_FF
- GSM7036894 TNBC_40_FF
+ 8 more — browse all 48 samples with per-sample file links →
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing · shares breast
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing · shares breast
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing · shares breast
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing · shares breast
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE267010 A consensus molecular subtypes classification strategy for clinical colorectal cancer tissues 104 samples shares classification, consensus
- GSE334033 A Patient-Derived Xenograft Model Identifies AK1 as a Key Regulator of Metastatic Potential in Primary Triple-Negative Breast Cancer 105 samples shares triple-negative, breast
- GSE291679 Lineage Tracing Reveals Clone-Specific Responses to Doxorubicin in Triple-Negative Breast Cancer 36 samples shares triple-negative, breast
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.